ARTICLE | Company News
Salix, Merck sales and marketing update
March 5, 2007 8:00 AM UTC
SLXP acquired gastrointestinal drugs Pepcid famotidine oral suspension and Diuril chlorothiazide oral suspension from MRK for $55 million up front. MRK is eligible for up to $6 million in sales-base...